Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly earnings of $0.44 per share which missed the analyst consensus estimate of $0.76 by 42.11 percent. This is a 30.16 percent decrease over earnings of $0.63 per share from the same period last year. The company reported quarterly sales of $58.800 million which missed the analyst consensus estimate of $62.392 million by 5.76 percent. This is a 10.32 percent increase over sales of $53.300 million the same period last year.